Wim Van Den Brink

Professor of Clinical Epidemiology in Addiction Care at the University of Amsterdam / Amsterdam UMC (emeritus professor)

Papers

6 publications

Trials

0 clinical trials

Links

Key Impact

He is a leading Dutch addiction psychiatrist whose expertise in substance use, harm reduction, and drug policy appears in psychedelics- and MDMA-related safety and policy research.

Background & Research

Wim van den Brink is a Dutch psychiatrist and addiction researcher associated with the University of Amsterdam and Amsterdam UMC. His work has focused on addiction epidemiology, treatment, and drug policy, including MDMA, cannabis, and other substance-related harms. He has also coauthored recent psychedelic-safety and psilocybin-related papers in clinical and policy contexts.

6

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

7 collaborators· click a node to visit their profile

Full network →